New Coverage-With-Evidence-Development Guidance In The Works Following MedCAC Meeting

The Medicare Evidence Development & Coverage Advisory Committee was charged May 16 with helping CMS better define the evidence threshold under which the agency should or should not pursue a coverage- with-evidence-development policy.

More from Policy & Regulation

More from Medtech Insight